Weekly Policy Update: The Colorado Experience, Tariff Advocacy, and FDA Funding News

COLORADO EXPERIENCE – BOULDER This week Jennifer Jones, Vice President of the Colorado BioScience Association, participated in the Denver Metro Chamber Leadership Foundation’s Colorado Experience two-...

Learn More

Weekly Policy Update: A Quick Review of President Trump’s Prescription Medication Plan

Last Friday President Trump unveiled his administration’s plan to help make prescription drugs more affordable for patients. The blueprint called “American Patients First" builds on the president's 20...

Learn More

Just-Released Economic Data Finds Improving Education in Colorado Would Generate Billions for the Economy

New statewide polling shows education is a top tier issue for Colorado voters and employers, alignment on improvement strategies May 15, 2018 – Denver – If Colorado schools were the best in the nation...

Learn More

Weekly Policy Update: Industry Defeats Harmful Transparency Measures at the Capitol

CBSA had a busy legislative session advocating on behalf the industry against transparency measures that stood to stifle bioscience innovation in Colorado and failed to provide the relief patients nee...

Learn More

Weekly Policy Update: HB-1358 Dies in Committee and Ongoing Transparency Advocacy

Advocating at the Capitol Today, April Giles, CBSA president & CEO testified in the House Health, Insurance, & Environment committee in opposition to HB18-1358 - Health Care Charges Billing Re...

Learn More

Weekly Policy Update: Action on Two Bills and Advocacy in DC

UNDER THE GOLD DOME This week, HB18-1135: Extend Advanced Industry Export Acceleration Program passed the Colorado House of Representatives and next week it moves to the Senate. This bill extends the...

Learn More

Weekly Policy Update: CBSA Takes Positions on Additional Bills, Transparency News, and China Tariffs

UNDER THE DOME The Colorado BioScience Association took formal positions on three bills this week. With 18 working days left of session we continue to evaluate and make recommendations on legislation...

Learn More

Weekly Policy Update: CO House Votes on Prescription Drug Price Transparency Bill Monday!

Colorado House Votes next week on Prescription Drug Price Transparency Bill (HB18-1260) CBSA continues to advocate against House Bill 1260, Prescription Drug Price Transparency. The bill could stifle...

Learn More

Weekly Policy Update: Colorado Budget and Forecast, plus a True Transparency update

CO State Budget & March Forecast Transportation, Education, PERA, and opioid addiction are a few of the areas that will receive funding in the $28.9 billion state budget package passed by the Colo...

Learn More

Weekly Policy Update: Advocacy Around Drug Transparency Issues, an Opportunity To Be Heard By the Next Governor, and the Omnibus Spending Bill

This week CBSA testified in opposition to House Bill 1009, Diabetes Drug Pricing Transparency Act 2018. The bill was heard in the House Health, Insurance and Environment Committee and passed on a part...

Learn More